These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17879594)

  • 1. Microarray analysis of laser capture microdissected substantia nigra pars compacta after a single administration of MPTP in common marmosets.
    Iwata S; Nomoto M; Miyata A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Aug; 27(4):161-6. PubMed ID: 17879594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.
    Przybyłkowski A; Kurkowska-Jastrzebska I; Joniec I; Ciesielska A; Członkowska A; Członkowski A
    Brain Res; 2004 Sep; 1019(1-2):144-51. PubMed ID: 15306248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson's disease.
    Reksidler AB; Lima MM; Dombrowski P; Andersen ML; Zanata SM; Andreatini R; Tufik S; Vital MA
    J Neurosci Methods; 2008 Jan; 167(2):268-77. PubMed ID: 17931705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of MPTP-induced dopaminergic neurodegeneration in the mouse substantia nigra by laser capture microdissection.
    Stephenson D; Ramirez A; Long J; Barrezueta N; Hajos-Korcsok E; Matherne C; Gallagher D; Ryan A; Ochoa R; Menniti F; Yan J
    J Neurosci Methods; 2007 Jan; 159(2):291-9. PubMed ID: 16949674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys.
    Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Izal-Azcárate A; Belzunegui S; Marcilla I; López B; Luquin MR
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):977-84. PubMed ID: 19680145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E; Yano R; Yokoyama H; Kato H; Araki T
    Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice.
    Bian GL; Wei LC; Shi M; Wang YQ; Cao R; Chen LW
    Brain Res; 2007 May; 1150():55-61. PubMed ID: 17397812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX; Chen WF; Xie JX; Wong MS
    Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pramipexole protects against MPTP toxicity in non-human primates.
    Iravani MM; Haddon CO; Cooper JM; Jenner P; Schapira AH
    J Neurochem; 2006 Mar; 96(5):1315-21. PubMed ID: 16464239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does melatonin help save dopaminergic cells in MPTP-treated mice?
    Ma J; Shaw VE; Mitrofanis J
    Parkinsonism Relat Disord; 2009 May; 15(4):307-14. PubMed ID: 18793863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toki-to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice.
    Sakai R; Irie Y; Murata T; Ishige A; Anjiki N; Watanabe K
    Phytother Res; 2007 Sep; 21(9):868-73. PubMed ID: 17486689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Optimization of counting process of dopaminergic neurons in substantia nigra of parkinsonian mice].
    Khaindrava VG; Ershov PV; Antsiperov VE; Obukhov IuV; Nanaev AK; Ugriumov MV
    Tsitologiia; 2010; 52(6):423-30. PubMed ID: 20737900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra.
    Jiang H; Li LJ; Wang J; Xie JX
    Exp Neurol; 2008 Aug; 212(2):532-7. PubMed ID: 18577498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling in progressively MPTP-lesioned macaques reveals molecular pathways associated with sporadic Parkinson's disease.
    Ohnuki T; Nakamura A; Okuyama S; Nakamura S
    Brain Res; 2010 Jul; 1346():26-42. PubMed ID: 20513370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys.
    Wallace BA; Ashkan K; Heise CE; Foote KD; Torres N; Mitrofanis J; Benabid AL
    Brain; 2007 Aug; 130(Pt 8):2129-45. PubMed ID: 17584773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra.
    Dietz GP; Stockhausen KV; Dietz B; Falkenburger BH; Valbuena P; Opazo F; Lingor P; Meuer K; Weishaupt JH; Schulz JB; Bähr M
    J Neurochem; 2008 Feb; 104(3):757-65. PubMed ID: 17995935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.
    Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF
    Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model.
    Jeon S; Kim YJ; Kim ST; Moon W; Chae Y; Kang M; Chung MY; Lee H; Hong MS; Chung JH; Joh TH; Lee H; Park HJ
    Proteomics; 2008 Nov; 8(22):4822-32. PubMed ID: 18942673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.